NLS PHARMACEUTICS LTD (NLSP)

CH0523961370 - Common Stock

3.365  +0.08 (+2.28%)

After market: 3.16 -0.21 (-6.09%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

NLS PHARMACEUTICS LTD

NASDAQ:NLSP (11/21/2024, 8:00:01 PM)

After market: 3.16 -0.21 (-6.09%)

3.365

+0.08 (+2.28%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-51.65%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap6.66M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NLSP Daily chart

Company Profile

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 3 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.

Company Info

NLS PHARMACEUTICS LTD

The Circle 6

Zurich ZUERICH CH-6370

P: 41445122150

CEO: Alexander Zwyer

Employees: 7

Website: https://nlspharma.com/

NLSP News

News Image4 days ago - ACCESSWIRENLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
ChartMill News Image18 days ago - ChartmillThese stocks are moving in today's pre-market session

Stay updated with the stocks that are on the move in Monday's pre-market session.

News Image25 days ago - ACCESSWIRENLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
News Imagea month ago - ACCESSWIRENLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
News Image2 months ago - ACCESSWIRENLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
News Image4 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!

NLSP Twits

Here you can normally see the latest stock twits on NLSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example